Sucrose Intolerance Congenital

DBCOND0148625Congenital, Hereditary, and Neonatal Diseases and AbnormalitiesDigestive System Diseases

Sucrose Intolerance Congenital is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as
Sucrase-isomaltase deficiency · Sucrase Isomaltase Deficiency · Disaccharide Intolerance I
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHT744857ICD-10E74.31SNOMED CT124457000MedDRA10066387UMLSC1283620

What you can answer from here — as of October 25, 2026

1Indicated drugWith each drug's targets and mechanism
Listed above
1Structured indicationPopulation, line of therapy, route and combination as fields, not prose
Sign in
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Contraindicated drugDrugs whose labels contraindicate them in this condition
Sign in

Which approved drugs for Sucrose Intolerance Congenital share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In